Episode 165: Diagnosing type 2 diabetes – as much magic as science
In episode 165, Mike and James talk about how should we diagnose type 2 diabetes and should we use A1c, FPG or OGTT or a magic crystal ball. At the end we come to the conclusion that you need to...
View ArticleEpisode 205: Please stop measuring all those A1c levels – PART II
In episode 205, Mike and James continue with their discussion on the use of A1c levels in type-2 diabetes. We discuss the variability in the measurement of A1c and given this, how tricky it is to use...
View ArticleTom Hanks and Type 2 Diabetes - an evidence-based discussion I would like to...
This is not actually a podcast but a quick audio note to let you know about a video I just released entitled "Tom Hanks and Type 2 Diabetes - an evidence-based discussion I would like to have with Mr....
View ArticleEpisode 283: PREMIUM – Glucose, blood pressure and statin studies to the max
In episode 283, Mike and James discuss the latest T2DM study showing that sitagliptin at least doesn’t cause much harm. We then veer off to discuss everything you need to know about diastolic and...
View ArticleEpisode 290: PREMIUM – Empagliflozin and the EMPA-REG OUTCOME study
In episode 290, James and Mike address listener demands for a discussion on the latest diabetes outcomes trial that looked at empagliflozin, a new class of medications for type-2 diabetes. This study...
View ArticleEpisode 320: PREMIUM – Our spin on the latest type 2 diabetes publications
In episode 320, Mike and James PREMIUM out yet again and talk about 3 new diabetes publications that our listeners have asked us about.Show notes1) LEADER StudyLiraglutide and Cardiovascular Outcomes...
View ArticleEpisode 330: PREMIUM – Diabetes, all the good, the bad and the ugly
In episode 330, Mike and James do a PREMIUM job of looking at 2 important new publications about medications for type 2 diabetes. We look at an RCT of semaglutide that actually shows a benefit. We then...
View Article
